• Profile
Close

ACTH following overnight dexamethasone suppression can be used in the verification of autonomous cortisol secretion in patients with adrenal incidentalomas

Clinical Endocrinology Jan 28, 2021

Puvaneswaralingam S, Kjellbom A, Lindgren O, et al. - Given the significance of accurately diagnosing autonomous cortisol secretion (ACS) during the investigation of adrenal incidentalomas, but a low specificity of cortisol ≥ 50 nmol/L after overnight dexamethasone suppression (cortisolONDST), researchers sought to examine if ACTH following overnight dexamethasone suppression (ACTHONDST) and cortisol following a 2‐day dexamethasone suppression test (cortisol2‐DAYDST) can aid in determining HPA axis suppression during ONDST. They conducted a cross‐sectional study including patients with adrenal incidentalomas and basal ACTH ≥ 2.0 pmol/L who underwent ONDST. Findings suggest the utility of ACTHONDST and ACTHONDST/ACTH ratio (ACTH ratio) as markers of HPA axis suppression in the evaluation of adrenal incidentalomas. They suggest that ACS should be suspected in cases with cortisolONDST ≥ 50 nmol/L with ACTHONDST < 0.6 pmol/L or ACTH ratio < 18%.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay